

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.46783106 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.46783106 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.08928056 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.08928056 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.65425020 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 6.09187763 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.05428188 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.93833209 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.93833209 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.93833209 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.93084313 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.91111855 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.77939337 |
| 14 | regulation of fibrinolysis (GO:0051917) | 5.76676446 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.69828374 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.58420719 |
| 17 | urea metabolic process (GO:0019627) | 5.50478045 |
| 18 | urea cycle (GO:0000050) | 5.50478045 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.43986230 |
| 20 | protein carboxylation (GO:0018214) | 5.43986230 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.43713410 |
| 22 | * regulation of protein activation cascade (GO:2000257) | 5.39133945 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.34012182 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.21794249 |
| 25 | cysteine metabolic process (GO:0006534) | 5.09790723 |
| 26 | bile acid metabolic process (GO:0008206) | 5.03852060 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.03667720 |
| 28 | * regulation of complement activation (GO:0030449) | 5.00890811 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.86480607 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78056489 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.77885742 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.71949831 |
| 33 | tyrosine metabolic process (GO:0006570) | 4.70141313 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.69291459 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.62508203 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.59068574 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.59068574 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.59068574 |
| 39 | lysine metabolic process (GO:0006553) | 4.54018089 |
| 40 | lysine catabolic process (GO:0006554) | 4.54018089 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.53562273 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.51861568 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.46141284 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.46141284 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.44260802 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.43739523 |
| 47 | coenzyme catabolic process (GO:0009109) | 4.42650701 |
| 48 | plasma lipoprotein particle clearance (GO:0034381) | 4.34483400 |
| 49 | bile acid and bile salt transport (GO:0015721) | 4.33578352 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.29157859 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.29157859 |
| 52 | phospholipid efflux (GO:0033700) | 4.24303095 |
| 53 | glycine metabolic process (GO:0006544) | 4.23897012 |
| 54 | cellular glucuronidation (GO:0052695) | 4.22607876 |
| 55 | fibrinolysis (GO:0042730) | 4.22088820 |
| 56 | glutamate metabolic process (GO:0006536) | 4.18907043 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 4.18019208 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.15686696 |
| 59 | cholesterol efflux (GO:0033344) | 4.14159541 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.12649368 |
| 61 | amine catabolic process (GO:0009310) | 4.07819337 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 4.07819337 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 4.06787641 |
| 64 | ethanol oxidation (GO:0006069) | 4.02157227 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 4.01276606 |
| 66 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00996076 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 3.97623789 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 3.97038198 |
| 69 | arginine metabolic process (GO:0006525) | 3.92541480 |
| 70 | aldehyde catabolic process (GO:0046185) | 3.88217187 |
| 71 | protein heterotrimerization (GO:0070208) | 3.84757415 |
| 72 | low-density lipoprotein particle remodeling (GO:0034374) | 3.84286041 |
| 73 | ketone body metabolic process (GO:1902224) | 3.83153489 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.83063417 |
| 75 | cofactor catabolic process (GO:0051187) | 3.79433840 |
| 76 | blood coagulation, intrinsic pathway (GO:0007597) | 3.75950965 |
| 77 | phospholipid homeostasis (GO:0055091) | 3.75303865 |
| 78 | regulation of plasminogen activation (GO:0010755) | 3.75108061 |
| 79 | opsonization (GO:0008228) | 3.74404666 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.73179057 |
| 81 | complement activation, classical pathway (GO:0006958) | 3.72949923 |
| 82 | uronic acid metabolic process (GO:0006063) | 3.72092212 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.72092212 |
| 84 | extracellular matrix assembly (GO:0085029) | 3.71709376 |
| 85 | drug catabolic process (GO:0042737) | 3.70879687 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.70108851 |
| 87 | acetyl-CoA metabolic process (GO:0006084) | 3.68717504 |
| 88 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.67474353 |
| 89 | postsynaptic membrane organization (GO:0001941) | 3.66808252 |
| 90 | regulation of cholesterol homeostasis (GO:2000188) | 3.65091351 |
| 91 | sterol homeostasis (GO:0055092) | 3.64071822 |
| 92 | cytolysis (GO:0019835) | 3.63691924 |
| 93 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63613392 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62171558 |
| 95 | organic acid catabolic process (GO:0016054) | 3.62012146 |
| 96 | carboxylic acid catabolic process (GO:0046395) | 3.62012146 |
| 97 | * protein activation cascade (GO:0072376) | 3.61036803 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60257353 |
| 99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60257353 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.58679945 |
| 101 | * complement activation (GO:0006956) | 3.57512003 |
| 102 | protein-lipid complex assembly (GO:0065005) | 3.56523879 |
| 103 | type B pancreatic cell proliferation (GO:0044342) | 3.56006219 |
| 104 | epoxygenase P450 pathway (GO:0019373) | 3.52626145 |
| 105 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.41371943 |
| 106 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.39622663 |
| 107 | cell migration involved in heart development (GO:0060973) | 3.37044594 |
| 108 | negative regulation of protein localization to cell surface (GO:2000009) | 3.36573209 |
| 109 | endocardial cushion development (GO:0003197) | 3.26072010 |
| 110 | presynaptic membrane assembly (GO:0097105) | 3.24873249 |
| 111 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.23550303 |
| 112 | cardiac myofibril assembly (GO:0055003) | 3.21376732 |
| 113 | collagen fibril organization (GO:0030199) | 3.17406227 |
| 114 | presynaptic membrane organization (GO:0097090) | 3.07635757 |
| 115 | cGMP-mediated signaling (GO:0019934) | 3.06302307 |
| 116 | omega-hydroxylase P450 pathway (GO:0097267) | 3.06293285 |
| 117 | bone trabecula formation (GO:0060346) | 2.98238442 |
| 118 | positive regulation of synapse assembly (GO:0051965) | 2.89359095 |
| 119 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.88354462 |
| 120 | dermatan sulfate biosynthetic process (GO:0030208) | 2.86902934 |
| 121 | exogenous drug catabolic process (GO:0042738) | 2.85200186 |
| 122 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.81754692 |
| 123 | negative regulation of axon guidance (GO:1902668) | 2.75266622 |
| 124 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.73891162 |
| 125 | blood vessel maturation (GO:0001955) | 2.71876441 |
| 126 | dermatan sulfate metabolic process (GO:0030205) | 2.68643767 |
| 127 | pericardium development (GO:0060039) | 2.67051807 |
| 128 | nucleobase catabolic process (GO:0046113) | 2.62474038 |
| 129 | axonal fasciculation (GO:0007413) | 2.59002906 |
| 130 | retinal rod cell development (GO:0046548) | 2.55921139 |
| 131 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.55524148 |
| 132 | tooth mineralization (GO:0034505) | 2.55262876 |
| 133 | L-serine metabolic process (GO:0006563) | 2.55033033 |
| 134 | glomerular basement membrane development (GO:0032836) | 2.52060208 |
| 135 | chondroitin sulfate catabolic process (GO:0030207) | 2.52030812 |
| 136 | astrocyte differentiation (GO:0048708) | 2.51379270 |
| 137 | midgut development (GO:0007494) | 2.50246487 |
| 138 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.50180600 |
| 139 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.49423509 |
| 140 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.46740667 |
| 141 | regulation of axon guidance (GO:1902667) | 2.46203040 |
| 142 | negative regulation of astrocyte differentiation (GO:0048712) | 2.43895470 |
| 143 | myofibril assembly (GO:0030239) | 2.43584980 |
| 144 | drug metabolic process (GO:0017144) | 2.42710108 |
| 145 | virion attachment to host cell (GO:0019062) | 2.42343136 |
| 146 | adhesion of symbiont to host cell (GO:0044650) | 2.42343136 |
| 147 | axon extension involved in axon guidance (GO:0048846) | 2.42317219 |
| 148 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.42317219 |
| 149 | response to magnesium ion (GO:0032026) | 2.41603391 |
| 150 | head development (GO:0060322) | 2.41073768 |
| 151 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.40563307 |
| 152 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.38427238 |
| 153 | positive regulation of gastrulation (GO:2000543) | 2.36713607 |
| 154 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.35725246 |
| 155 | venous blood vessel morphogenesis (GO:0048845) | 2.35188949 |
| 156 | peripheral nervous system neuron development (GO:0048935) | 2.34787271 |
| 157 | skin morphogenesis (GO:0043589) | 2.34640831 |
| 158 | mechanoreceptor differentiation (GO:0042490) | 2.32132327 |
| 159 | regulation of synapse assembly (GO:0051963) | 2.31803477 |
| 160 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.31311677 |
| 161 | retinal ganglion cell axon guidance (GO:0031290) | 2.30759789 |
| 162 | alkaloid metabolic process (GO:0009820) | 2.29598426 |
| 163 | neuron recognition (GO:0008038) | 2.28627716 |
| 164 | retinal cone cell development (GO:0046549) | 2.27400914 |
| 165 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.26099922 |
| 166 | outer ear morphogenesis (GO:0042473) | 2.25922958 |
| 167 | xenobiotic catabolic process (GO:0042178) | 2.24326404 |
| 168 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.24239078 |
| 169 | positive regulation of cartilage development (GO:0061036) | 2.23960834 |
| 170 | regulation of the force of heart contraction (GO:0002026) | 2.22844523 |
| 171 | regulation of organ formation (GO:0003156) | 2.22248221 |
| 172 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.20712332 |
| 173 | cell proliferation involved in kidney development (GO:0072111) | 2.19075767 |
| 174 | cell communication by electrical coupling (GO:0010644) | 2.18929294 |
| 175 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.18621788 |
| 176 | positive regulation of male gonad development (GO:2000020) | 2.17099458 |
| 177 | embryonic forelimb morphogenesis (GO:0035115) | 2.16344343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.97567323 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.76481653 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.52217980 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.27902981 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.97643922 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.68563241 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.61328415 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.46977402 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01826095 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.57214234 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.33465649 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27793562 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.07400464 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.07257093 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.05204451 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.03106433 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01304361 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4165361 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.92282642 |
| 20 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.91058196 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90980919 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.89932350 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89763448 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88067299 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.86403792 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.85104813 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.85104813 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79909928 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75419163 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.73975444 |
| 31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72108446 |
| 32 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.71169254 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70093722 |
| 34 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.69483861 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 1.66057551 |
| 36 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.65828615 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65689416 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61438309 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61367645 |
| 40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.59662057 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56068094 |
| 42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55911901 |
| 43 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.52002935 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.49797398 |
| 45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49209437 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47122047 |
| 47 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45196172 |
| 48 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43293458 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41247133 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40393860 |
| 51 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37624640 |
| 52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36498095 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33942574 |
| 54 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33589733 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29936105 |
| 56 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29482674 |
| 57 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29316489 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29208932 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25346113 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22547820 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21608213 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20161390 |
| 63 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.19719091 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18357515 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16806433 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16362211 |
| 67 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15068659 |
| 68 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14926196 |
| 69 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14282890 |
| 70 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13558392 |
| 71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13500538 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12211845 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11655734 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11655734 |
| 75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11397616 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11287135 |
| 77 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.11225600 |
| 78 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.11077726 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09855982 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08861612 |
| 81 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08304914 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07661466 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07461626 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07379603 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07334920 |
| 86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06565939 |
| 87 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05251693 |
| 88 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05225416 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03918661 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03393965 |
| 91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02612447 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02565895 |
| 93 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01939798 |
| 94 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01750199 |
| 95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01078711 |
| 96 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00512448 |
| 97 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98548248 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98494635 |
| 99 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97602689 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96883860 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96382828 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95540298 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95407749 |
| 104 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95225660 |
| 105 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93734244 |
| 106 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93107953 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90350986 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89279386 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88826942 |
| 110 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88099929 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86186371 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83613843 |
| 113 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82915861 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81402474 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76104571 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74747697 |
| 117 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.74309359 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.73896785 |
| 119 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.73605189 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72803252 |
| 121 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.70647796 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66607166 |
| 123 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.65317300 |
| 124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.64090564 |
| 125 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.61223473 |
| 126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60494634 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60313044 |
| 128 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59862043 |
| 129 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57795388 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57528933 |
| 131 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57491581 |
| 132 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.57145888 |
| 133 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55791598 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55202374 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54420748 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54059593 |
| 137 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53983159 |
| 138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53586378 |
| 139 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53566617 |
| 140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.53020553 |
| 141 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.51499749 |
| 142 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50611372 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.50390580 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.50168737 |
| 145 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.49970365 |
| 146 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.49316285 |
| 147 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49293385 |
| 148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.49210434 |
| 149 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.48737186 |
| 150 | CJUN_26792858_Chip-Seq_BT549_Human | 0.47496120 |
| 151 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.46736245 |
| 152 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.46298732 |
| 153 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.45595199 |
| 154 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44363052 |
| 155 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.44103454 |
| 156 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.44103454 |
| 157 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.42546894 |
| 158 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42471639 |
| 159 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42192231 |
| 160 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.41304678 |
| 161 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41124696 |
| 162 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.41071193 |
| 163 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.40760859 |
| 164 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.40565498 |
| 165 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40413520 |
| 166 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39921964 |
| 167 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39406878 |
| 168 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.39348620 |
| 169 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39343124 |
| 170 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.38868353 |
| 171 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38596396 |
| 172 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.38338765 |
| 173 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38265594 |
| 174 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38227927 |
| 175 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.38214567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.12211784 |
| 2 | MP0005360_urolithiasis | 7.51411463 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.36632544 |
| 4 | MP0005365_abnormal_bile_salt | 6.00460085 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.91110591 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.20095975 |
| 7 | MP0003252_abnormal_bile_duct | 4.06510499 |
| 8 | MP0003136_yellow_coat_color | 3.97149518 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.49015029 |
| 10 | MP0001958_emphysema | 3.47218522 |
| 11 | MP0009840_abnormal_foam_cell | 3.13817856 |
| 12 | MP0004272_abnormal_basement_membrane | 3.11558920 |
| 13 | MP0005083_abnormal_biliary_tract | 3.10851334 |
| 14 | MP0006054_spinal_hemorrhage | 2.81917600 |
| 15 | MP0003195_calcinosis | 2.77710384 |
| 16 | MP0005332_abnormal_amino_acid | 2.61913596 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.45503866 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.44212933 |
| 19 | MP0005171_absent_coat_pigmentation | 2.37740388 |
| 20 | MP0005257_abnormal_intraocular_pressure | 2.23015338 |
| 21 | MP0000751_myopathy | 2.06066120 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.05033001 |
| 23 | MP0000609_abnormal_liver_physiology | 2.04901758 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.04449946 |
| 25 | MP0004858_abnormal_nervous_system | 2.00769355 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.94017061 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.89789857 |
| 28 | MP0003868_abnormal_feces_composition | 1.89300737 |
| 29 | MP0005508_abnormal_skeleton_morphology | 1.78909644 |
| 30 | MP0001542_abnormal_bone_strength | 1.77476665 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.69657596 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.61225602 |
| 33 | MP0009697_abnormal_copulation | 1.60254315 |
| 34 | MP0003942_abnormal_urinary_system | 1.56992275 |
| 35 | MP0002108_abnormal_muscle_morphology | 1.52609521 |
| 36 | MP0000049_abnormal_middle_ear | 1.52078224 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.46786083 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44987031 |
| 39 | MP0001764_abnormal_homeostasis | 1.38096815 |
| 40 | MP0000778_abnormal_nervous_system | 1.37308155 |
| 41 | MP0000534_abnormal_ureter_morphology | 1.35872750 |
| 42 | MP0001529_abnormal_vocalization | 1.33832197 |
| 43 | MP0005451_abnormal_body_composition | 1.30099595 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.26517242 |
| 45 | MP0001299_abnormal_eye_distance/ | 1.25268835 |
| 46 | MP0003011_delayed_dark_adaptation | 1.24541569 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.22925083 |
| 48 | MP0004859_abnormal_synaptic_plasticity | 1.22191874 |
| 49 | MP0009250_abnormal_appendicular_skeleto | 1.18330149 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.16576176 |
| 51 | MP0000604_amyloidosis | 1.14397911 |
| 52 | MP0000598_abnormal_liver_morphology | 1.14019036 |
| 53 | MP0003880_abnormal_central_pattern | 1.11215891 |
| 54 | MP0005647_abnormal_sex_gland | 1.10450626 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.08409380 |
| 56 | MP0003950_abnormal_plasma_membrane | 1.08213568 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.06269977 |
| 58 | MP0000767_abnormal_smooth_muscle | 1.05967385 |
| 59 | MP0003385_abnormal_body_wall | 1.05235372 |
| 60 | MP0004885_abnormal_endolymph | 1.03183892 |
| 61 | MP0003186_abnormal_redox_activity | 1.02559487 |
| 62 | MP0000538_abnormal_urinary_bladder | 1.01097307 |
| 63 | MP0000428_abnormal_craniofacial_morphol | 1.01038031 |
| 64 | MP0002254_reproductive_system_inflammat | 1.00314518 |
| 65 | MP0000026_abnormal_inner_ear | 0.98354652 |
| 66 | MP0002102_abnormal_ear_morphology | 0.98307033 |
| 67 | MP0004133_heterotaxia | 0.97867636 |
| 68 | MP0009384_cardiac_valve_regurgitation | 0.96061837 |
| 69 | MP0009053_abnormal_anal_canal | 0.95881059 |
| 70 | MP0004084_abnormal_cardiac_muscle | 0.95487059 |
| 71 | MP0004142_abnormal_muscle_tone | 0.95454682 |
| 72 | MP0009763_increased_sensitivity_to | 0.93818073 |
| 73 | MP0005408_hypopigmentation | 0.92394910 |
| 74 | MP0001984_abnormal_olfaction | 0.92068998 |
| 75 | MP0003755_abnormal_palate_morphology | 0.91755275 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.90982977 |
| 77 | MP0002736_abnormal_nociception_after | 0.88761613 |
| 78 | MP0002896_abnormal_bone_mineralization | 0.87414420 |
| 79 | MP0005620_abnormal_muscle_contractility | 0.86946621 |
| 80 | MP0009764_decreased_sensitivity_to | 0.85262266 |
| 81 | MP0002115_abnormal_skeleton_extremities | 0.84543410 |
| 82 | MP0005423_abnormal_somatic_nervous | 0.84496164 |
| 83 | MP0003937_abnormal_limbs/digits/tail_de | 0.82440748 |
| 84 | MP0000163_abnormal_cartilage_morphology | 0.82233776 |
| 85 | MP0003091_abnormal_cell_migration | 0.82020307 |
| 86 | MP0003115_abnormal_respiratory_system | 0.81305545 |
| 87 | MP0003329_amyloid_beta_deposits | 0.80853707 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.80037221 |
| 89 | MP0000749_muscle_degeneration | 0.78838089 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.78072603 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.77281474 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 0.77025989 |
| 93 | MP0003634_abnormal_glial_cell | 0.77012745 |
| 94 | MP0002653_abnormal_ependyma_morphology | 0.76797940 |
| 95 | MP0001661_extended_life_span | 0.75465383 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.75208498 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.74455620 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.74185392 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.73631448 |
| 100 | MP0004130_abnormal_muscle_cell | 0.72942373 |
| 101 | MP0010386_abnormal_urinary_bladder | 0.72807150 |
| 102 | MP0002116_abnormal_craniofacial_bone | 0.71970956 |
| 103 | MP0005670_abnormal_white_adipose | 0.71018657 |
| 104 | MP0002233_abnormal_nose_morphology | 0.70275339 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.68670173 |
| 106 | MP0002127_abnormal_cardiovascular_syste | 0.68613043 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.68594617 |
| 108 | MP0000955_abnormal_spinal_cord | 0.68183075 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.67961096 |
| 110 | MP0002971_abnormal_brown_adipose | 0.67809068 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.67706410 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.67704822 |
| 113 | MP0004145_abnormal_muscle_electrophysio | 0.67174382 |
| 114 | MP0003690_abnormal_glial_cell | 0.66933793 |
| 115 | MP0008469_abnormal_protein_level | 0.66898413 |
| 116 | MP0005275_abnormal_skin_tensile | 0.66611909 |
| 117 | MP0000462_abnormal_digestive_system | 0.65651354 |
| 118 | MP0001270_distended_abdomen | 0.65613733 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.65338306 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.64587136 |
| 121 | MP0005330_cardiomyopathy | 0.63655925 |
| 122 | MP0000566_synostosis | 0.63456577 |
| 123 | MP0000432_abnormal_head_morphology | 0.63351174 |
| 124 | MP0005334_abnormal_fat_pad | 0.61855806 |
| 125 | MP0003935_abnormal_craniofacial_develop | 0.61406936 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.60156280 |
| 127 | MP0005395_other_phenotype | 0.57990928 |
| 128 | MP0002295_abnormal_pulmonary_circulatio | 0.56749379 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.55945988 |
| 130 | MP0000579_abnormal_nail_morphology | 0.55810458 |
| 131 | MP0002060_abnormal_skin_morphology | 0.55598311 |
| 132 | MP0006036_abnormal_mitochondrial_physio | 0.55294266 |
| 133 | MP0001243_abnormal_dermal_layer | 0.54947905 |
| 134 | MP0002168_other_aberrant_phenotype | 0.53245570 |
| 135 | MP0005266_abnormal_metabolism | 0.52173184 |
| 136 | MP0005448_abnormal_energy_balance | 0.51375821 |
| 137 | MP0005535_abnormal_body_temperature | 0.50558978 |
| 138 | MP0005023_abnormal_wound_healing | 0.49222395 |
| 139 | MP0001756_abnormal_urination | 0.48722852 |
| 140 | MP0004883_abnormal_blood_vessel | 0.46105727 |
| 141 | MP0003279_aneurysm | 0.45795387 |
| 142 | MP0002928_abnormal_bile_duct | 0.45081843 |
| 143 | MP0005503_abnormal_tendon_morphology | 0.43114242 |
| 144 | MP0006035_abnormal_mitochondrial_morpho | 0.40221790 |
| 145 | MP0005187_abnormal_penis_morphology | 0.38332054 |
| 146 | MP0009672_abnormal_birth_weight | 0.37958555 |
| 147 | MP0005164_abnormal_response_to | 0.37640538 |
| 148 | MP0005666_abnormal_adipose_tissue | 0.37046151 |
| 149 | MP0003718_maternal_effect | 0.36254457 |
| 150 | MP0008874_decreased_physiological_sensi | 0.35890996 |
| 151 | MP0008873_increased_physiological_sensi | 0.34574713 |
| 152 | MP0005595_abnormal_vascular_smooth | 0.34348652 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.34008821 |
| 154 | MP0000249_abnormal_blood_vessel | 0.33075321 |
| 155 | MP0002269_muscular_atrophy | 0.32119985 |
| 156 | MP0002282_abnormal_trachea_morphology | 0.30918045 |
| 157 | MP0003953_abnormal_hormone_level | 0.30744240 |
| 158 | MP0002136_abnormal_kidney_physiology | 0.30655409 |
| 159 | MP0005464_abnormal_platelet_physiology | 0.29650587 |
| 160 | MP0002796_impaired_skin_barrier | 0.29585324 |
| 161 | MP0002128_abnormal_blood_circulation | 0.28729597 |
| 162 | MP0003075_altered_response_to | 0.28695330 |
| 163 | MP0000230_abnormal_systemic_arterial | 0.28570387 |
| 164 | MP0002249_abnormal_larynx_morphology | 0.28149309 |
| 165 | MP0005166_decreased_susceptibility_to | 0.27471727 |
| 166 | MP0001881_abnormal_mammary_gland | 0.27395080 |
| 167 | MP0002090_abnormal_vision | 0.26954349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.83886885 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.45053663 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.15137302 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.58726692 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.51139230 |
| 6 | Xanthomatosis (HP:0000991) | 6.35676045 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.30157349 |
| 8 | Complement deficiency (HP:0004431) | 5.53575179 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.39357716 |
| 10 | Premature rupture of membranes (HP:0001788) | 5.35546159 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.79543001 |
| 12 | Follicular hyperkeratosis (HP:0007502) | 4.78406677 |
| 13 | Vascular tortuosity (HP:0004948) | 4.69616908 |
| 14 | Aortic aneurysm (HP:0004942) | 4.67466170 |
| 15 | Joint hemorrhage (HP:0005261) | 4.65218525 |
| 16 | Epidermoid cyst (HP:0200040) | 4.62057752 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.61842501 |
| 18 | Hyperammonemia (HP:0001987) | 4.43180131 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36797445 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.24147050 |
| 21 | Neonatal short-limb short stature (HP:0008921) | 4.23727532 |
| 22 | Hyperglycinemia (HP:0002154) | 4.16691928 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 4.11351274 |
| 24 | Fat malabsorption (HP:0002630) | 4.10154761 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.09721808 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09187083 |
| 27 | Ankle contracture (HP:0006466) | 4.08048239 |
| 28 | Ketosis (HP:0001946) | 4.06037793 |
| 29 | Abnormality of complement system (HP:0005339) | 4.02257804 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.92841710 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 3.92308890 |
| 32 | Aortic dissection (HP:0002647) | 3.91823239 |
| 33 | Broad metatarsal (HP:0001783) | 3.83839929 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80483071 |
| 35 | Soft skin (HP:0000977) | 3.77392663 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.73761248 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.70815750 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.70815750 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.60477395 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.57027789 |
| 41 | Hyperglycinuria (HP:0003108) | 3.53417044 |
| 42 | Abnormality of dentin (HP:0010299) | 3.52793305 |
| 43 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.46708874 |
| 44 | Bladder diverticulum (HP:0000015) | 3.43159194 |
| 45 | Hyperbilirubinemia (HP:0002904) | 3.22425482 |
| 46 | Skin nodule (HP:0200036) | 3.19372923 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.18135263 |
| 48 | Spontaneous abortion (HP:0005268) | 3.16997264 |
| 49 | Arterial tortuosity (HP:0005116) | 3.14574562 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.12655424 |
| 51 | Myocardial infarction (HP:0001658) | 3.11356566 |
| 52 | Shallow orbits (HP:0000586) | 3.06067323 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 3.04046779 |
| 54 | Steatorrhea (HP:0002570) | 3.00389809 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.86533846 |
| 56 | Slender build (HP:0001533) | 2.86378140 |
| 57 | Delayed CNS myelination (HP:0002188) | 2.86325350 |
| 58 | Ketoacidosis (HP:0001993) | 2.81190241 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.79111417 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77519230 |
| 61 | Mitral stenosis (HP:0001718) | 2.77175239 |
| 62 | Wormian bones (HP:0002645) | 2.75019152 |
| 63 | * Wide anterior fontanel (HP:0000260) | 2.73102033 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.62314706 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.59751772 |
| 66 | Biconcave vertebral bodies (HP:0004586) | 2.56978355 |
| 67 | Aortic regurgitation (HP:0001659) | 2.55790736 |
| 68 | Vascular calcification (HP:0004934) | 2.55714570 |
| 69 | Acanthocytosis (HP:0001927) | 2.54917751 |
| 70 | Cholelithiasis (HP:0001081) | 2.53196711 |
| 71 | Spastic diplegia (HP:0001264) | 2.50877011 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.50242694 |
| 73 | Metabolic acidosis (HP:0001942) | 2.50155065 |
| 74 | Mitral regurgitation (HP:0001653) | 2.44923030 |
| 75 | * Coronal craniosynostosis (HP:0004440) | 2.44899413 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.43984280 |
| 77 | Cholecystitis (HP:0001082) | 2.43984280 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.42924408 |
| 79 | Spinal rigidity (HP:0003306) | 2.39578599 |
| 80 | Short 4th metacarpal (HP:0010044) | 2.36785837 |
| 81 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.36785837 |
| 82 | Glomerulonephritis (HP:0000099) | 2.34883679 |
| 83 | Bowel diverticulosis (HP:0005222) | 2.34452195 |
| 84 | Atrophic scars (HP:0001075) | 2.32469287 |
| 85 | Polyphagia (HP:0002591) | 2.31469356 |
| 86 | Increased corneal curvature (HP:0100692) | 2.30744909 |
| 87 | Keratoconus (HP:0000563) | 2.30744909 |
| 88 | Lethargy (HP:0001254) | 2.30343553 |
| 89 | Neonatal onset (HP:0003623) | 2.28266763 |
| 90 | Hypoglycemic seizures (HP:0002173) | 2.27970418 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.27801184 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27801184 |
| 93 | Amyloidosis (HP:0011034) | 2.25697437 |
| 94 | Septo-optic dysplasia (HP:0100842) | 2.25224611 |
| 95 | Calcaneovalgus deformity (HP:0001848) | 2.22232306 |
| 96 | Pulmonary artery stenosis (HP:0004415) | 2.20360703 |
| 97 | Abnormal delivery (HP:0001787) | 2.18389075 |
| 98 | Infantile muscular hypotonia (HP:0008947) | 2.18288998 |
| 99 | Irritability (HP:0000737) | 2.17527286 |
| 100 | Cervical subluxation (HP:0003308) | 2.17266794 |
| 101 | Gingival bleeding (HP:0000225) | 2.17170901 |
| 102 | Deformed tarsal bones (HP:0008119) | 2.16857726 |
| 103 | Cerebral edema (HP:0002181) | 2.16260464 |
| 104 | Hypoventilation (HP:0002791) | 2.14553708 |
| 105 | Menorrhagia (HP:0000132) | 2.14466029 |
| 106 | Peritonitis (HP:0002586) | 2.13182386 |
| 107 | Esophageal varix (HP:0002040) | 2.12731788 |
| 108 | Gout (HP:0001997) | 2.11868461 |
| 109 | Opisthotonus (HP:0002179) | 2.10428005 |
| 110 | Malnutrition (HP:0004395) | 2.10397337 |
| 111 | Abnormality of the gallbladder (HP:0005264) | 2.10010953 |
| 112 | Hemiparesis (HP:0001269) | 2.09310870 |
| 113 | Sensorimotor neuropathy (HP:0007141) | 2.07054919 |
| 114 | Aortic valve stenosis (HP:0001650) | 2.06793228 |
| 115 | Limited hip movement (HP:0008800) | 2.04057441 |
| 116 | Overgrowth (HP:0001548) | 2.03958797 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 2.02971756 |
| 118 | Joint laxity (HP:0001388) | 2.02877978 |
| 119 | Enlarged kidneys (HP:0000105) | 2.01864569 |
| 120 | Hemorrhage of the eye (HP:0011885) | 2.01529214 |
| 121 | Hyperextensible skin (HP:0000974) | 2.00575672 |
| 122 | Synostosis involving bones of the feet (HP:0009140) | 1.98091569 |
| 123 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.98091569 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97862453 |
| 125 | Hypophosphatemic rickets (HP:0004912) | 1.97595633 |
| 126 | Abnormality of the calf musculature (HP:0001430) | 1.97423078 |
| 127 | Increased variability in muscle fiber diameter (HP:0003557) | 1.96203352 |
| 128 | Breech presentation (HP:0001623) | 1.96199556 |
| 129 | Vertebral compression fractures (HP:0002953) | 1.94050480 |
| 130 | Thrombophlebitis (HP:0004418) | 1.93925771 |
| 131 | Occipital encephalocele (HP:0002085) | 1.93276192 |
| 132 | Partial duplication of the phalanx of hand (HP:0009999) | 1.92363656 |
| 133 | Tarsal synostosis (HP:0008368) | 1.90941897 |
| 134 | Morphological abnormality of the middle ear (HP:0008609) | 1.90732776 |
| 135 | Dilatation of the ascending aorta (HP:0005111) | 1.90636927 |
| 136 | Pancreatitis (HP:0001733) | 1.90440052 |
| 137 | Rickets (HP:0002748) | 1.90399430 |
| 138 | Wrist flexion contracture (HP:0001239) | 1.90119447 |
| 139 | Hip contracture (HP:0003273) | 1.89521870 |
| 140 | Lymphangioma (HP:0100764) | 1.89389888 |
| 141 | Brushfield spots (HP:0001088) | 1.87972489 |
| 142 | Hydroxyprolinuria (HP:0003080) | 1.87805702 |
| 143 | Abnormality of proline metabolism (HP:0010907) | 1.87805702 |
| 144 | Aneurysm (HP:0002617) | 1.87530767 |
| 145 | Abnormality of the 4th metacarpal (HP:0010012) | 1.87387089 |
| 146 | Poikilocytosis (HP:0004447) | 1.85175658 |
| 147 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84863057 |
| 148 | Ulnar bowing (HP:0003031) | 1.84660749 |
| 149 | Blue sclerae (HP:0000592) | 1.84107381 |
| 150 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83896326 |
| 151 | Back pain (HP:0003418) | 1.83499803 |
| 152 | Vomiting (HP:0002013) | 1.82934446 |
| 153 | Long toe (HP:0010511) | 1.82152456 |
| 154 | Late onset (HP:0003584) | 1.81354522 |
| 155 | Protrusio acetabuli (HP:0003179) | 1.80120417 |
| 156 | Atelectasis (HP:0100750) | 1.79507274 |
| 157 | Abnormality of iron homeostasis (HP:0011031) | 1.78737031 |
| 158 | Turricephaly (HP:0000262) | 1.78375508 |
| 159 | Nephritis (HP:0000123) | 1.77952570 |
| 160 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77181897 |
| 161 | Synostosis involving the elbow (HP:0003938) | 1.77112589 |
| 162 | Humeroradial synostosis (HP:0003041) | 1.77112589 |
| 163 | Hyperglycemia (HP:0003074) | 1.76741583 |
| 164 | Abnormality of the Achilles tendon (HP:0005109) | 1.73947839 |
| 165 | Genu recurvatum (HP:0002816) | 1.73854481 |
| 166 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73322507 |
| 167 | Camptodactyly of toe (HP:0001836) | 1.72779731 |
| 168 | Natal tooth (HP:0000695) | 1.72250926 |
| 169 | Mitral valve prolapse (HP:0001634) | 1.71495028 |
| 170 | Generalized aminoaciduria (HP:0002909) | 1.71017915 |
| 171 | Limb-girdle muscle weakness (HP:0003325) | 1.68696240 |
| 172 | Abnormality of the acetabulum (HP:0003170) | 1.68105184 |
| 173 | Atrial fibrillation (HP:0005110) | 1.67723521 |
| 174 | Broad ribs (HP:0000885) | 1.66515552 |
| 175 | Fragile skin (HP:0001030) | 1.66449101 |
| 176 | Ectopia lentis (HP:0001083) | 1.66289399 |
| 177 | Partial duplication of thumb phalanx (HP:0009944) | 1.64233848 |
| 178 | True hermaphroditism (HP:0010459) | 1.63803977 |
| 179 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.61575124 |
| 180 | Micromelia (HP:0002983) | 1.60540010 |
| 181 | Abnormality of the diencephalon (HP:0010662) | 1.59714058 |
| 182 | Inguinal hernia (HP:0000023) | 1.59700071 |
| 183 | Redundant skin (HP:0001582) | 1.58786194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.72139228 |
| 2 | SIK1 | 4.92082534 |
| 3 | FGFR4 | 3.96081211 |
| 4 | ERN1 | 3.87944511 |
| 5 | MARK1 | 3.31669377 |
| 6 | ERBB4 | 3.28485402 |
| 7 | NTRK2 | 3.20646149 |
| 8 | CASK | 3.02249154 |
| 9 | LATS1 | 2.77137205 |
| 10 | TRIB3 | 2.55647736 |
| 11 | PKN2 | 2.54075571 |
| 12 | INSRR | 2.45824450 |
| 13 | TAOK3 | 2.33635746 |
| 14 | FGFR2 | 2.08395898 |
| 15 | MAP2K4 | 1.98850343 |
| 16 | ADRBK2 | 1.98509899 |
| 17 | PIK3CG | 1.81766019 |
| 18 | GRK7 | 1.75793929 |
| 19 | GRK1 | 1.72166737 |
| 20 | TNIK | 1.72046566 |
| 21 | MST1R | 1.69941261 |
| 22 | DMPK | 1.69667188 |
| 23 | PTK6 | 1.64200944 |
| 24 | WNK4 | 1.63910788 |
| 25 | MAPK11 | 1.60542541 |
| 26 | ABL2 | 1.49958736 |
| 27 | NEK9 | 1.45421308 |
| 28 | PNCK | 1.44684717 |
| 29 | FLT3 | 1.44048538 |
| 30 | DDR2 | 1.41946885 |
| 31 | OBSCN | 1.41549171 |
| 32 | EPHB1 | 1.40881553 |
| 33 | PDGFRA | 1.37801260 |
| 34 | MAPK13 | 1.37461865 |
| 35 | MET | 1.35112145 |
| 36 | PAK6 | 1.33787973 |
| 37 | MAP3K10 | 1.31624159 |
| 38 | NTRK3 | 1.28839630 |
| 39 | AKT3 | 1.26941485 |
| 40 | LATS2 | 1.24789393 |
| 41 | FRK | 1.24495537 |
| 42 | ADRBK1 | 1.24252518 |
| 43 | PLK2 | 1.24251355 |
| 44 | DYRK2 | 1.22699285 |
| 45 | ERBB2 | 1.19120724 |
| 46 | EPHA3 | 1.17504157 |
| 47 | TTN | 1.16867218 |
| 48 | PAK3 | 1.16050539 |
| 49 | MAP4K2 | 1.15104666 |
| 50 | DAPK2 | 1.14777645 |
| 51 | MAPKAPK3 | 1.13440144 |
| 52 | STK38L | 1.10733611 |
| 53 | MAP3K7 | 1.10715931 |
| 54 | PRKD3 | 1.09536188 |
| 55 | EPHB2 | 1.05739037 |
| 56 | LIMK1 | 1.05721637 |
| 57 | ROCK2 | 1.03460592 |
| 58 | RIPK1 | 1.03457645 |
| 59 | PTK2 | 1.02114195 |
| 60 | WNK3 | 0.99033912 |
| 61 | TYK2 | 0.98343220 |
| 62 | KIT | 0.97654841 |
| 63 | PRKAA2 | 0.96372980 |
| 64 | CAMK2D | 0.94848449 |
| 65 | PDK2 | 0.93213781 |
| 66 | STK38 | 0.92763393 |
| 67 | PKN1 | 0.91536419 |
| 68 | PRKCZ | 0.91521374 |
| 69 | JAK1 | 0.91355426 |
| 70 | PRKD2 | 0.90112634 |
| 71 | JAK2 | 0.88040520 |
| 72 | KDR | 0.85265734 |
| 73 | PIK3CA | 0.84574388 |
| 74 | PRKCE | 0.83715065 |
| 75 | CDC42BPA | 0.83260376 |
| 76 | GRK5 | 0.82594322 |
| 77 | CAMK1D | 0.82100677 |
| 78 | MAPK4 | 0.81498328 |
| 79 | STK39 | 0.80273146 |
| 80 | CAMK2G | 0.80174746 |
| 81 | MOS | 0.79644783 |
| 82 | NUAK1 | 0.79520940 |
| 83 | TYRO3 | 0.79378413 |
| 84 | DYRK1B | 0.78718088 |
| 85 | PTK2B | 0.78125348 |
| 86 | MAPK12 | 0.77959191 |
| 87 | BCR | 0.76083979 |
| 88 | BMX | 0.74798958 |
| 89 | CAMK2B | 0.74306937 |
| 90 | GSK3A | 0.74064914 |
| 91 | ICK | 0.70823456 |
| 92 | CAMK2A | 0.70343091 |
| 93 | CSNK1G1 | 0.70075319 |
| 94 | CAMK1 | 0.70003448 |
| 95 | TGFBR2 | 0.68479591 |
| 96 | MTOR | 0.68302565 |
| 97 | CDK6 | 0.68268469 |
| 98 | PRKACG | 0.65592653 |
| 99 | PAK2 | 0.65072799 |
| 100 | RET | 0.63733176 |
| 101 | PRKAA1 | 0.63397268 |
| 102 | FGFR1 | 0.62513940 |
| 103 | MAP2K1 | 0.60808375 |
| 104 | MAP2K3 | 0.56532179 |
| 105 | STK3 | 0.55430632 |
| 106 | CDK5 | 0.54388002 |
| 107 | TBK1 | 0.53438292 |
| 108 | RPS6KA2 | 0.52764669 |
| 109 | BMPR1B | 0.52209404 |
| 110 | SGK3 | 0.50482268 |
| 111 | CSNK1A1L | 0.49698148 |
| 112 | MAPK7 | 0.49503431 |
| 113 | EPHA4 | 0.49172282 |
| 114 | CSNK1G2 | 0.49138337 |
| 115 | MAP3K4 | 0.48266159 |
| 116 | CAMK1G | 0.47859651 |
| 117 | ERBB3 | 0.46869438 |
| 118 | WNK1 | 0.46786490 |
| 119 | CSNK1G3 | 0.46530129 |
| 120 | PINK1 | 0.46456941 |
| 121 | PDPK1 | 0.46168744 |
| 122 | IGF1R | 0.46090630 |
| 123 | FGFR3 | 0.45768382 |
| 124 | CSF1R | 0.44532090 |
| 125 | PHKG1 | 0.44247012 |
| 126 | PHKG2 | 0.44247012 |
| 127 | PRKD1 | 0.43835735 |
| 128 | SGK223 | 0.43319741 |
| 129 | SGK494 | 0.43319741 |
| 130 | PIM2 | 0.42034305 |
| 131 | PRKCG | 0.41584096 |
| 132 | FER | 0.41392523 |
| 133 | PBK | 0.40994435 |
| 134 | PRKG1 | 0.40902512 |
| 135 | MAP3K3 | 0.40213078 |
| 136 | NTRK1 | 0.38357001 |
| 137 | PRKCH | 0.37857351 |
| 138 | MYLK | 0.37379713 |
| 139 | PRKACA | 0.37224830 |
| 140 | PRKCQ | 0.36200739 |
| 141 | TRPM7 | 0.35270920 |
| 142 | MAPK15 | 0.35010507 |
| 143 | MAP2K7 | 0.34169759 |
| 144 | INSR | 0.33895118 |
| 145 | ROCK1 | 0.33164751 |
| 146 | CSK | 0.32694542 |
| 147 | EGFR | 0.30876895 |
| 148 | PRKACB | 0.30162387 |
| 149 | CAMK4 | 0.28866274 |
| 150 | PDGFRB | 0.27094026 |
| 151 | TIE1 | 0.26560132 |
| 152 | SGK2 | 0.26331675 |
| 153 | TAOK2 | 0.25378235 |
| 154 | ABL1 | 0.24720093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53380424 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.88130336 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40832979 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.27219351 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06428563 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.84379387 |
| 7 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83394086 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66647636 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62124588 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55960904 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48591895 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34925861 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21400347 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09776864 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06112093 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.99570192 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94927693 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90220036 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89960241 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87605704 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87245940 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87088584 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86458234 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.79377697 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77318349 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70743367 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64739410 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63790602 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62469745 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56621382 |
| 31 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54858038 |
| 32 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.53474727 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52250126 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51110644 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.49655741 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49499968 |
| 37 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.46045103 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.43801180 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40632635 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40631500 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39919617 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.37413148 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36768988 |
| 44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.36267705 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35682567 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25651370 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22653821 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18552097 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.14241312 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12214269 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11181299 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10724841 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04035937 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03267522 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01725848 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98097243 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.95237635 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89236798 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 0.87603195 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87008777 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.85912739 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84756880 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83228307 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82804092 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79410360 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76964602 |
| 67 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75737584 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75106941 |
| 69 | Melanogenesis_Homo sapiens_hsa04916 | 0.71025578 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69690858 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.68740796 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66343940 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65181815 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62692151 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60881424 |
| 76 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.59770246 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59429879 |
| 78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.58306808 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58193089 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57155973 |
| 81 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56634410 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56252941 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56230455 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55564131 |
| 85 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53182925 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52532358 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51963907 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51858968 |
| 89 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50330227 |
| 90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50262070 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47593661 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46766326 |
| 93 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45699782 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.43653270 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43612951 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42131247 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41763423 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41029750 |
| 99 | Melanoma_Homo sapiens_hsa05218 | 0.39752765 |
| 100 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39610515 |
| 101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39079681 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36747193 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26202255 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.24938034 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24310375 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23149536 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20037868 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16531876 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10870797 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.10382938 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10166525 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08205155 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06905051 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04884756 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2101056 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2050131 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | -0.1991182 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1973891 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1944153 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1926604 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1914261 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1829451 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1693236 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1666430 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1652266 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1428751 |
| 127 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1250987 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1195977 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1037632 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1027759 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | -0.0846326 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | -0.0691140 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0615830 |

